Omnicell Investor Presentation Deck slide image

Omnicell Investor Presentation Deck

Total Year Revenue Composition. GAAP ($Million) Connected Devices, Software Licenses, & Other Consumables Technical Services Advanced Services Total Revenue 2 Advanced Services % of Total Revenue Recurring % of Total Revenue © 2023 Omnicell, Inc. Recurring vs Non Recurring Non Recurring Category Product Recurring Product Recurring Service Recurring Service Actual TY-2020 $560 $76 $202 $54 $892 6% 37% Year over Year (YoY) Change % -2% -12% 4% 24% -1% Actual TY-2021 $739 $73 $207 $113 $1,132 10% 35% YOY Change % 32% -3% 2% 109% 27% Actual TY-2022 $828 $75 $207 $186 $1,296 14% 36% YOY Change % 12% 3% 0% 65% 14% YOY Updated Guidance Change % TY-2023 (Mid-Point) $740-$760 $215-$225 $205-$215 $1,160-$1,200 18% 1. Connected Devices, Software Licenses, and other include, but are not limited to, XT Series automated dispensing systems and products related to Central Pharmacy Dispensing Service and IV Compounding Service. 2. Includes Central Pharmacy Dispensing Service (service portion), IV Compounding Service (service portion), EnlivenHealth solutions, Specialty Pharmacy Services, 340B solutions, Inventory Optimization Service, and other software solutions. -17% 6% 13% -9% 14
View entire presentation